文献速递复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

儿童脓毒症延迟抗菌治疗与一年死亡率的相关性

Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis.
PubMed 文献 · Shock · 2017-01-01
一句话结论儿童严重脓毒症中,识别脓毒症后1小时内或超过3小时给予抗菌治疗均与一年死亡率升高相关,1至3小时内给药未见此关联。

本研究为回顾性观察性研究,纳入2012年2月1日至2013年6月30日期间某四级学术儿童重症监护病房(PICU)收治的160例年龄≤21岁的严重脓毒症患者。以脓毒症识别至抗菌药物给药的时间间隔为暴露变量,采用多因素Cox和logistic回归分析其与一年死亡率的关系。总体一年死亡率为24%(39例),其中46%死于指数PICU出院后。校正疾病严重程度和合并症后,给药延迟至3小时内的每小时延迟与一年死亡率无关;但与1至3小时内给药相比,≤1小时给药(aOR 3.8,95% CI 1.2,11.7)和>3小时给药(aOR 3.5,95% CI 1.3,9.8)均与一年死亡率升高相关。在存活出PICU的亚组中,≤1小时给药也与一年死亡率升高相关(aOR 5.5,95% CI 1.1,27.4),而>3小时给药则无显著关联(aOR 2.2,95% CI 0.5,11.0)。作者认为≤1小时给药与一年死亡率升高的发现应视为假设生成,供未来研究验证。

要点

  • 儿童严重脓毒症总体一年死亡率为24%(39/160),其中46%的死亡发生在PICU出院后。
  • 与脓毒症识别后1至3小时内给予抗菌药物相比,≤1小时给药与一年死亡率升高相关(aOR 3.8,95% CI 1.2,11.7)。
  • 与1至3小时内给药相比,>3小时给药也与一年死亡率升高相关(aOR 3.5,95% CI 1.3,9.8)。
  • 在存活出PICU的亚组中,≤1小时给药与一年死亡率升高相关(aOR 5.5,95% CI 1.1,27.4),>3小时给药无显著关联(aOR 2.2,95% CI 0.5,11.0)。
  • 校正疾病严重程度和合并症后,给药延迟至3小时内的每小时延迟与一年死亡率无关。

适用人群与场景

  • 年龄≤21岁、因严重脓毒症在四级学术儿童重症监护病房(PICU)治疗的患者,研究期间为2012年2月1日至2013年6月30日。

研究设计与关键结果

  • 研究类型为回顾性观察性研究,样本量160例,单中心(四级学术儿童重症监护病房),人群为年龄≤21岁的严重脓毒症患者,无干预措施。
  • 主要终点为一年死亡率:总体24%(39例),其中46%的死亡发生在指数PICU出院后。
  • 脓毒症识别至抗菌药物给药的中位时间为137分钟(IQR 65-287)。
  • 校正疾病严重程度和合并症后,与1至3小时内给药相比,≤1小时给药的一年死亡率aOR 3.8(95% CI 1.2,11.7),>3小时给药aOR 3.5(95% CI 1.3,9.8);给药延迟至3小时内的每小时延迟与一年死亡率无关。
  • 在存活出PICU的亚组中,与1至3小时内给药相比,≤1小时给药的一年死亡率aOR 5.5(95% CI 1.1,27.4),>3小时给药aOR 2.2(95% CI 0.5,11.0)。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症识别后≤1小时给予抗菌治疗与一年死亡率升高的发现应视为假设生成,供未来研究验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Delayed antimicrobial therapy in sepsis is associated with increased hospital mortality, but the impact of antimicrobial timing on long-term outcomes is unknown. We tested the hypothesis that hourly delays to antimicrobial therapy are associated with 1-year mortality in pediatric severe sepsis.

DESIGN: Retrospective observational study.

SETTING: Quaternary academic pediatric intensive care unit (PICU) from February 1, 2012 to June 30, 2013.

PATIENTS: One hundred sixty patients aged ≤21 years treated for severe sepsis.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We tested the association of hourly delays from sepsis recognition to antimicrobial administration with 1-year mortality using multivariable Cox and logistic regression. Overall 1-year mortality was 24% (39 patients), of whom 46% died after index PICU discharge. Median time from sepsis recognition to antimicrobial therapy was 137 min (IQR 65-287). After adjusting for severity of illness and comorbid conditions, hourly delays up to 3 h were not associated with 1-year mortality. However, increased 1-year mortality was evident in patients who received antimicrobials ≤1 h (aOR 3.8, 95% CI 1.2, 11.7) or >3 h (aOR 3.5, 95% CI 1.3, 9.8) compared with patients who received antimicrobials within 1 to 3 h from sepsis recognition. For the subset of patients who survived index PICU admission, antimicrobial therapy ≤1 h was also associated with increased 1-year mortality (aOR 5.5, 95% CI 1.1, 27.4), while antimicrobial therapy >3 h was not associated with 1-year mortality (aOR 2.2, 95% CI 0.5, 11.0).

CONCLUSIONS: Hourly delays to antimicrobial therapy, up to 3 h, were not associated with 1-year mortality in pediatric severe sepsis in this study. The finding that antimicrobial therapy ≤1 h from sepsis recognition was associated with increased 1-year mortality should be regarded as hypothesis-generating for future studies.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Han M, Fitzgerald JC, Balamuth F, et al. Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis. Shock. 2017. PMID: 28114166. doi:10.1097/SHK.0000000000000833

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。